These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 37280220)

  • 1. Drug screening at single-organoid resolution via bioprinting and interferometry.
    Tebon PJ; Wang B; Markowitz AL; Davarifar A; Tsai BL; Krawczuk P; Gonzalez AE; Sartini S; Murray GF; Nguyen HTL; Tavanaie N; Nguyen TL; Boutros PC; Teitell MA; Soragni A
    Nat Commun; 2023 Jun; 14(1):3168. PubMed ID: 37280220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D bioprinting for organ and organoid models and disease modeling.
    Juraski AC; Sharma S; Sparanese S; da Silva VA; Wong J; Laksman Z; Flannigan R; Rohani L; Willerth SM
    Expert Opin Drug Discov; 2023; 18(9):1043-1059. PubMed ID: 37431937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immersion bioprinting of hyaluronan and collagen bioink-supported 3D patient-derived brain tumor organoids.
    Clark CC; Yoo KM; Sivakumar H; Strumpf K; Laxton AW; Tatter SB; Strowd RE; Skardal A
    Biomed Mater; 2022 Dec; 18(1):. PubMed ID: 36332268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications.
    Maharjan S; Ma C; Singh B; Kang H; Orive G; Yao J; Shrike Zhang Y
    Adv Drug Deliv Rev; 2024 May; 208():115237. PubMed ID: 38447931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation.
    Dai R; Chen W; Chen Y; Jin J; Zhang S; Zhang C; Liu J
    Biofabrication; 2024 Jun; 16(3):. PubMed ID: 38810618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Speed Live-Cell Interferometry: A New Method for Quantifying Tumor Drug Resistance and Heterogeneity.
    Huang D; Leslie KA; Guest D; Yeshcheulova O; Roy IJ; Piva M; Moriceau G; Zangle TA; Lo RS; Teitell MA; Reed J
    Anal Chem; 2018 Mar; 90(5):3299-3306. PubMed ID: 29381859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation.
    Lawlor KT; Vanslambrouck JM; Higgins JW; Chambon A; Bishard K; Arndt D; Er PX; Wilson SB; Howden SE; Tan KS; Li F; Hale LJ; Shepherd B; Pentoney S; Presnell SC; Chen AE; Little MH
    Nat Mater; 2021 Feb; 20(2):260-271. PubMed ID: 33230326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels.
    Mollica PA; Booth-Creech EN; Reid JA; Zamponi M; Sullivan SM; Palmer XL; Sachs PC; Bruno RD
    Acta Biomater; 2019 Sep; 95():201-213. PubMed ID: 31233891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening.
    Hou S; Tiriac H; Sridharan BP; Scampavia L; Madoux F; Seldin J; Souza GR; Watson D; Tuveson D; Spicer TP
    SLAS Discov; 2018 Jul; 23(6):574-584. PubMed ID: 29673279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustic Bioprinting of Patient-Derived Organoids for Predicting Cancer Therapy Responses.
    Chen H; Wu Z; Gong Z; Xia Y; Li J; Du L; Zhang Y; Gao X; Fan Z; Hu H; Qian Q; Ding Z; Guo S
    Adv Healthc Mater; 2022 Jul; 11(13):e2102784. PubMed ID: 35358375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric Bioprinting of Organoids and Optically Tuned Hydrogels to Build Liver-Like Metabolic Biofactories.
    Bernal PN; Bouwmeester M; Madrid-Wolff J; Falandt M; Florczak S; Rodriguez NG; Li Y; Größbacher G; Samsom RA; van Wolferen M; van der Laan LJW; Delrot P; Loterie D; Malda J; Moser C; Spee B; Levato R
    Adv Mater; 2022 Apr; 34(15):e2110054. PubMed ID: 35166410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
    Deben C; De La Hoz EC; Compte ML; Van Schil P; Hendriks JMH; Lauwers P; Yogeswaran SK; Lardon F; Pauwels P; Van Laere S; Bogaerts A; Smits E; Vanlanduit S; Lin A
    Cell Oncol (Dordr); 2023 Apr; 46(2):299-314. PubMed ID: 36508089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent and reproducible cultures of large-scale 3D mammary epithelial structures using an accessible bioprinting platform.
    Reid JA; Mollica PA; Bruno RD; Sachs PC
    Breast Cancer Res; 2018 Oct; 20(1):122. PubMed ID: 30305139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converging bioprinting and organoids to better recapitulate the tumor microenvironment.
    Wang X; Luo Y; Ma Y; Wang P; Yao R
    Trends Biotechnol; 2024 May; 42(5):648-663. PubMed ID: 38071145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Message in a Scaffold: Natural Biomaterials for Three-Dimensional (3D) Bioprinting of Human Brain Organoids.
    Layrolle P; Payoux P; Chavanas S
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
    Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
    Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments and Opportunities for 3D Bioprinted Organoids.
    Ren Y; Yang X; Ma Z; Sun X; Zhang Y; Li W; Yang H; Qiang L; Yang Z; Liu Y; Deng C; Zhou L; Wang T; Lin J; Li T; Wu T; Wang J
    Int J Bioprint; 2021; 7(3):364. PubMed ID: 34286150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of 3D bioprinting technology in creating human tissue and organoid models for preclinical drug research - State-of-the-art.
    Frankowski J; Kurzątkowska M; Sobczak M; Piotrowska U
    Int J Pharm; 2023 Sep; 644():123313. PubMed ID: 37579828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Bio-fabrication of Organoid Cultures.
    Peng W; Datta P; Wu Y; Dey M; Ayan B; Dababneh A; Ozbolat IT
    Adv Exp Med Biol; 2018; 1107():53-71. PubMed ID: 29855825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay establishment and validation of a high-throughput organoid-based drug screening platform.
    Li X; Fu G; Zhang L; Guan R; Tang P; Zhang J; Rao X; Chen S; Xu X; Zhou Y; Deng Y; Lv T; He X; Mo S; Mu P; Gao J; Hua G
    Stem Cell Res Ther; 2022 May; 13(1):219. PubMed ID: 35619149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.